$CAH News

RBC Capital Initiates Coverage of Cardinal Health (CAH) with Outperform Recommendation

RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path

Cardinal Health CEO details M&A strategy and growth

CAH Q2 CY2026 Deep Dive: Specialty Momentum, Strategic Investments, and Guidance Above Street Expectations

Cardinal Health Stock Hits a Record High After Earnings: Is CAH Still a Buy?

TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Cardinal Health: Q4 Presents Positive Signal For The Company's Long-Term Growth

Cardinal Health (CAH) Stock Looks About Right On Earnings But Stretched On Broader Checks

CAH Q4 Earnings Call Centers on Fiscal 2027 Growth Outlook

Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250

UBS Maintains Buy on Cardinal Health, Raises Price Target to $280

Cardinal Health Analysts Increase Their Forecasts Following Q4 Results

Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277

Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274

Cardinal Health Inc (CAH) (Q4 2026) Earnings Call Highlights: Record EPS Growth and Robust ...